Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) represented a move of 8.23 percent or $-1.69 per share and closed its previous day trading session at $19.19. 600034 Shares were traded in the last trading session with an Average Volume of 436.29 Million Shares. The stock currently has a Market Capitalization of 1.04 Billion.
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
The stock traded between $ 7.85 and $22.67 over 1-Year time period showing its price to sales ratio of 3458.68. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $16.63 and 200-Day Simple Moving Average of $33.04. Its Price to Free Cash Flow is 0 and Price to Book of 2.61.
Analyst’s recommended the stock as 1.6 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) reported its Actual EPS of $-0.53/share. The analysts offering Earnings Estimates for the company were believing that Intra-Cellular Therapies, Inc. could bring EPS of $-0.62/share. The difference between Actual EPS and Estimated EPS was 0.09 Percent. Thus showing an Earnings Surprise of 14.5 Percent.
Capital Product Partners L.P. (NASDAQ:CPLP)
In the last trading session, Capital Product Partners L.P. (NASDAQ:CPLP) added its value by 3.54% closing at the price of $3.22. The stock currently has market capitalization of 439.24 Million, with average volume of 501.27 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Capital Product Partners L.P. (NASDAQ:CPLP) is showing beta of 1.22. This particular value of beta suggests that Capital Product Partners L.P. (NASDAQ:CPLP) has historically moved 122% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Capital Product Partners L.P. (NASDAQ:CPLP) is at $0.22.
The stock currently has RSI of 45.5. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
CAPITAL PRODUCT PARTNERS L.P. is an international shipping company and leader in the seaborne transportation of refined oil products and chemicals. Their fleet of product tankers is fully chartered under medium- to long-term time and bareboat charters. With their modern, state-of-the-art fleet and built-in growth through contracted acquisitions of additional vessels and the potential drop-down of optional vessels from the owner of their General Partner, Capital Maritime & Trading Corp., they are well-positioned to capitalize on the growth dynamics of the product tanker industry, worldwide, as well as pending regulatory changes.
Capital Product Partners L.P. (NASDAQ:CPLP) topped its 52-week high price of $4.00 on 07/17/17 and 52-Week Low Price of $2.98 on 02/09/18. The Stock currently has P/E (price to earnings ttm) of 14.77 and Weekly volatility of 4.90% and monthly volatility of 3.09% respectively.